Related Experiment Video
Updated: Jun 19, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
Effects of Biguanide-PROTACs in Pancreatic Cancer Cells
Julie Vatté1, Véronique Bourdeau2, Gerardo Ferbeyre2,3
1Département de Chimie, Faculté des Arts et des Sciences, Université de Montréal, 1375 a. Thérèse Lavoie-Roux, Montréal, QC H2V 0B3, Canada.
Abstract:
This study focuses on the synthesis of Biguanide-PROTACs, formed by conjugating the biguanide motif with a spacer and a ligand for recognition subunits of two E3 ubiquitin ligases. Evaluation of their activity on pancreatic cancer cell (KP4) proliferation established a correlation between membrane permeability and median effective concentration. Mechanistic insights revealed that only two compounds exhibited biguanide-like AMPK activation, while only one hydrophobic compound uniquely altered mitochondrial protein levels. The prospect of developing and expanding the Biguanide-PROTAC library holds several promises, offering potential insights into biguanide mechanisms and the creation of more potent anticancer agents. This study contributes to understanding the intricate interplay between compound structure, permeability, and anticancer activity, paving the way for targeted drug development in pancreatic cancer treatment.

